{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Prednisolone Sodium Phosphate is a prescription oral solution, a generic corticosteroid medication used to reduce inflammation and treat conditions like allergies, arthritis, and certain skin disorders. Each 5 mL contains the equivalent of 20 mg of prednisolone base. Manufactured by PAI Holdings, LLC dba PAI Pharma. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Prednisolone sodium phosphate \u2014 ANDA 203559 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203559", "mediaType": "text/html", "title": "Prednisolone sodium phosphate"}], "identifier": "ANDA203559", "issued": "2016-09-16", "keyword": ["health-care", "prescription-drugs", "drug-manufacturers", "pharmaceuticals", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Prednisolone sodium phosphate"}